BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 33098831)

  • 1. Therapeutic effect of uridine phosphorylase 1 (UPP1) inhibitor on liver fibrosis in vitro and in vivo.
    Gonçalves da Silva EF; Costa BP; Nassr MT; de Souza Basso B; Bastos MS; Antunes GL; Reghelin CK; Rosa Garcia MC; Schneider Levorse VG; Carlessi LP; Antunes Fernandes KH; Richter Schmitz CR; Haute GV; Luft C; Santarém E; Barbé-Tuana FM; Donadio MVF; Basso LA; Machado P; Rodrigues de Oliveira J
    Eur J Pharmacol; 2021 Jan; 890():173670. PubMed ID: 33098831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CPBMF65, a synthetic human uridine phosphorylase-1 inhibitor, reduces HepG2 cell proliferation through cell cycle arrest and senescence.
    da Silva EFG; Lima KG; Krause GC; Haute GV; Pedrazza L; Catarina AV; Gassen RB; de Souza Basso B; Dias HB; Luft C; Garcia MCR; Costa BP; Antunes GL; Basso LA; Donadio MVF; Machado P; de Oliveira JR
    Invest New Drugs; 2020 Dec; 38(6):1653-1663. PubMed ID: 32367200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pirfenidone inhibits carbon tetrachloride- and albumin complex-induced liver fibrosis in rodents by preventing activation of hepatic stellate cells.
    Zhao XY; Zeng X; Li XM; Wang TL; Wang BE
    Clin Exp Pharmacol Physiol; 2009 Oct; 36(10):963-8. PubMed ID: 19413596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protecting effects of vasonatrin peptide against carbon tetrachloride-induced liver fibrosis.
    Chen BY; Qu P; Tie R; Zhu MZ; Zhu XX; Yu J
    Regul Pept; 2010 Sep; 164(2-3):139-43. PubMed ID: 20619296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indole-3-carbinol enhances the resolution of rat liver fibrosis and stimulates hepatic stellate cell apoptosis by blocking the inhibitor of κB kinase α/inhibitor of κB-α/nuclear factor-κB pathway.
    Ping J; Gao AM; Qin HQ; Wei XN; Bai J; Liu L; Li XH; Li RW; Ao Y; Wang H
    J Pharmacol Exp Ther; 2011 Nov; 339(2):694-703. PubMed ID: 21862660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic antifibrotic efficacy of statin and protein kinase C inhibitor in hepatic fibrosis.
    Yang JI; Yoon JH; Bang YJ; Lee SH; Lee SM; Byun HJ; Myung SJ; Kim W; Lee HS
    Am J Physiol Gastrointest Liver Physiol; 2010 Jan; 298(1):G126-32. PubMed ID: 19910526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
    Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
    Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells
    Li Z; Ding Q; Ling LP; Wu Y; Meng DX; Li X; Zhang CQ
    World J Gastroenterol; 2018 Feb; 24(7):819-832. PubMed ID: 29467552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pien-Tze-Huang ameliorates hepatic fibrosis via suppressing NF-κB pathway and promoting HSC apoptosis.
    Zheng H; Wang X; Zhang Y; Chen L; Hua L; Xu W
    J Ethnopharmacol; 2019 Nov; 244():111856. PubMed ID: 30959141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angelica sinensis polysaccharide attenuates CCl
    Wang K; Wang J; Song M; Wang H; Xia N; Zhang Y
    Int J Biol Macromol; 2020 Nov; 162():273-283. PubMed ID: 32569681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis
    Zou GL; Zuo S; Lu S; Hu RH; Lu YY; Yang J; Deng KS; Wu YT; Mu M; Zhu JJ; Zeng JZ; Zhang BF; Wu X; Zhao XK; Li HY
    World J Gastroenterol; 2019 Aug; 25(30):4222-4234. PubMed ID: 31435175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imidazoline I2 receptor inhibitor idazoxan regulates the progression of hepatic fibrosis via Akt-Nrf2-Smad2/3 signaling pathway.
    Xuanfei L; Hao C; Zhujun Y; Yanming L; Jianping G
    Oncotarget; 2017 Mar; 8(13):21015-21030. PubMed ID: 28423499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. d-amino acid modification protects N-Acetyl-seryl-aspartyl-lysyl-proline from physiological hydroxylation and increases its antifibrotic effects on hepatic fibrosis.
    Zhang X; Zhou J; Zhu Y; He L; Pang Z; Wang Z; Xu C; Zhang C; Hao Q; Li W; Zhang W; Zhang Y; Li M
    IUBMB Life; 2019 Sep; 71(9):1302-1312. PubMed ID: 30900390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nrf2 knockdown attenuates the ameliorative effects of ligustrazine on hepatic fibrosis by targeting hepatic stellate cell transdifferentiation.
    Lu C; Xu W; Zhang F; Shao J; Zheng S
    Toxicology; 2016 Jul; 365():35-47. PubMed ID: 27477297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ampelopsin attenuates carbon tetrachloride-induced mouse liver fibrosis and hepatic stellate cell activation associated with the SIRT1/TGF-β1/Smad3 and autophagy pathway.
    Ma JQ; Sun YZ; Ming QL; Tian ZK; Yang HX; Liu CM
    Int Immunopharmacol; 2019 Dec; 77():105984. PubMed ID: 31677501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stephania tetrandra prevents and regresses liver fibrosis induced by carbon tetrachloride in rats.
    Chor JS; Yu J; Chan KK; Go YY; Sung JJ
    J Gastroenterol Hepatol; 2009 May; 24(5):853-9. PubMed ID: 19220659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geniposide, a sonic hedgehog signaling inhibitor, inhibits the activation of hepatic stellate cell.
    Lin X; Li J; Xing YQ
    Int Immunopharmacol; 2019 Jul; 72():330-338. PubMed ID: 31005778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential therapeutic effects of a traditional Chinese formulation, BJ-JN, on liver fibrosis induced by carbon tetrachloride in rats.
    Zou YH; Yang Y; Li J; Wu Q; Li WP; Lu JT; Roberts MS
    J Ethnopharmacol; 2008 Dec; 120(3):452-7. PubMed ID: 18951966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumol induces RIPK1/RIPK3 complex-dependent necroptosis via JNK1/2-ROS signaling in hepatic stellate cells.
    Jia Y; Wang F; Guo Q; Li M; Wang L; Zhang Z; Jiang S; Jin H; Chen A; Tan S; Zhang F; Shao J; Zheng S
    Redox Biol; 2018 Oct; 19():375-387. PubMed ID: 30237126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel STAT3 inhibitor, STX-0119, attenuates liver fibrosis by inactivating hepatic stellate cells in mice.
    Choi S; Jung HJ; Kim MW; Kang JH; Shin D; Jang YS; Yoon YS; Oh SH
    Biochem Biophys Res Commun; 2019 May; 513(1):49-55. PubMed ID: 30935693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.